Recent Updates
Recently added Catalysts
ACHC Positive Sentiment

Acadia Healthcare Announces Third Quarter 2026 Results and Raises Full Year 2026 Financial Guidance

Wednesday, November 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Acadia Healthcare Company reported its third quarter 2026 results, revealing a revenue of $895.3 million, up 5.1% from the previous year. Same-facility revenue also increased by 5.2%, driven by a 1.1% rise in patient days and a 4.0% increase in revenue per patient day. The company has raised its full-year financial guidance.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenue increased by 5.1% year-over-year.
  • Same-facility revenue rose by 5.2%.
  • Net income attributable to Acadia showed positive growth.

Full Press Release Details

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Results Revenue totaled $895.3 million, an increase of 5.1% compared with the third quarter of 2025 Same-facility revenue increased 5.2% compared with the third quarter of 2025, as patient days increased 1.1% and revenue per patient day increased 4.0% Net income attributable to Acadia tot

Frequently Asked Questions

What was Acadia's revenue for Q3 2026?

Acadia's revenue for Q3 2026 was $895.3 million.

How much did same-facility revenue increase?

Same-facility revenue increased by 5.2% compared to Q3 2025.

What factors contributed to revenue growth?

Patient days increased by 1.1% and revenue per patient day rose by 4.0%.

Did Acadia raise its financial guidance?

Yes, Acadia raised its full-year financial guidance following the results.

ShareAdd on Google
Tags: ACHC Acadia Healthcare Q3 2026 financial results revenue increase
Last updated: Nov 4, 2026

Biotech snapshot

Cash runway
$171M liquidity · $0M/mo burn
Low dilution risk